GLENVIEW, Ill. — Mead Johnson Nutrition on Friday expanded the size of its board from 11 to 12 members and appointed Michael Grobstein as its newest director. He is a retired vice chairman of Ernst & Young, one of the world's largest professional services organizations.
Grobstein, 71, is currently on the board of directors of Bristol-Myers Squibb, where he is a member of the audit committee, as well as the compensation and management development committees. He also was a director of Given Imaging, where he served on several committees and was chair of the audit committee, until its recent acquisition by Covidien.
Having joined Ernst & Young in 1964, Grobstein was made a partner in 1975. He served as a vice chairman from 1984 until his retirement in 1998. During that period, he held a series of companywide leadership positions that included responsibility for accounting and auditing services; planning, marketing and industry services; and areas of international operations.
Grobstein currently serves on the boards of the Central Park Conservancy and the Peer Health Exchange.
"Mike's knowledge of accounting, internal controls and financial reporting rules and regulations — along with his varied experience serving on the boards of several global companies — will add additional depth and strength to the broad expertise of our current board," stated James Cornelius, chairman of the Mead Johnson board.